Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants

Summary

The purpose of the study is to assess the bioavailability (the extent to which a medication becomes available to the body) of subcutaneously (under the skin using a needle) administered sirukumab and to compare the pharmacokinetics of sirukumab administered subcutaneously using a pre-filled syringe fitted with the UltraSafe Passive™ Delivery system (PFS-U) with the SmartJect™ Autoinjector (PFS-AI) in healthy male participants.

Timeline

Start

2014-03

Primary completion

2015-01

Completion

2015-01

Drugs

Indications

No indication recorded.